MetLife, Inc. (NYSE:MET – Get Free Report)’s stock price gapped down before the market opened on Thursday after Barclays lowered their price target on the stock from $91.00 to $90.00. The stock had previously closed at $83.18, but opened at $76.57. Barclays currently has an overweight rating on the stock. MetLife shares last traded at $77.81, with a volume of 541,401 shares traded.
Other equities research analysts also recently issued reports about the stock. Keefe, Bruyette & Woods cut their target price on shares of MetLife from $86.00 to $85.00 and set an “outperform” rating on the stock in a research note on Monday, July 8th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Friday, October 4th. Bank of America decreased their target price on MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a report on Thursday, August 1st. Wells Fargo & Company upped their price target on MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Finally, Jefferies Financial Group lifted their price objective on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.38.
Get Our Latest Analysis on MET
Institutional Inflows and Outflows
MetLife Trading Up 0.0 %
The business’s 50 day simple moving average is $80.59 and its 200 day simple moving average is $74.84. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market capitalization of $54.93 billion, a price-to-earnings ratio of 15.81, a price-to-earnings-growth ratio of 0.69 and a beta of 1.04.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.15. MetLife had a return on equity of 20.41% and a net margin of 5.27%. The firm had revenue of $17.82 billion for the quarter, compared to analysts’ expectations of $18.57 billion. During the same quarter in the previous year, the firm posted $1.94 EPS. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. Research analysts anticipate that MetLife, Inc. will post 8.58 EPS for the current year.
MetLife Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.78%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio (DPR) is presently 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Trading Halts Explained
- Battle of the Retailers: Who Comes Out on Top?
- What is the FTSE 100 index?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Are Penny Stocks a Good Fit for Your Portfolio?
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.